vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $199.5M, roughly 2.0× VIRTUS INVESTMENT PARTNERS, INC.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 3.6%, a 1.7% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.

GRDN vs VRTS — Head-to-Head

Bigger by revenue
GRDN
GRDN
2.0× larger
GRDN
$397.6M
$199.5M
VRTS
Higher net margin
GRDN
GRDN
1.7% more per $
GRDN
5.3%
3.6%
VRTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GRDN
GRDN
VRTS
VRTS
Revenue
$397.6M
$199.5M
Net Profit
$20.9M
$7.1M
Gross Margin
21.5%
Operating Margin
7.7%
7.7%
Net Margin
5.3%
3.6%
Revenue YoY
-4.1%
Net Profit YoY
-78.1%
EPS (diluted)
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
VRTS
VRTS
Q1 26
$199.5M
Q4 25
$397.6M
$208.0M
Q3 25
$377.4M
$216.4M
Q2 25
$344.3M
$210.5M
Q1 25
$329.3M
$217.9M
Q4 24
$233.5M
Q3 24
$314.4M
$227.0M
Q2 24
$224.4M
Net Profit
GRDN
GRDN
VRTS
VRTS
Q1 26
$7.1M
Q4 25
$20.9M
$33.9M
Q3 25
$9.8M
$31.3M
Q2 25
$9.0M
$42.7M
Q1 25
$9.4M
$28.1M
Q4 24
$39.5M
Q3 24
$-122.0M
$49.1M
Q2 24
$26.0M
Gross Margin
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
21.5%
Q3 25
19.8%
Q2 25
19.8%
Q1 25
19.5%
Q4 24
Q3 24
19.4%
Q2 24
Operating Margin
GRDN
GRDN
VRTS
VRTS
Q1 26
7.7%
Q4 25
7.7%
19.1%
Q3 25
4.3%
21.7%
Q2 25
3.7%
21.5%
Q1 25
3.9%
16.8%
Q4 24
21.7%
Q3 24
-33.3%
24.3%
Q2 24
19.7%
Net Margin
GRDN
GRDN
VRTS
VRTS
Q1 26
3.6%
Q4 25
5.3%
16.3%
Q3 25
2.6%
14.5%
Q2 25
2.6%
20.3%
Q1 25
2.9%
12.9%
Q4 24
16.9%
Q3 24
-38.8%
21.6%
Q2 24
11.6%
EPS (diluted)
GRDN
GRDN
VRTS
VRTS
Q1 26
$1.05
Q4 25
$5.15
Q3 25
$4.65
Q2 25
$6.12
Q1 25
$4.05
Q4 24
$4.65
Q3 24
$5.71
Q2 24
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
VRTS
VRTS
Cash + ST InvestmentsLiquidity on hand
$65.6M
$136.6M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$93.6B
Total Assets
$412.7M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
VRTS
VRTS
Q1 26
$136.6M
Q4 25
$65.6M
Q3 25
$36.5M
Q2 25
$18.8M
Q1 25
$14.0M
Q4 24
Q3 24
$37.2M
Q2 24
Total Debt
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
$0
$390.0M
Q3 25
$390.6M
Q2 25
$231.3M
Q1 25
$231.7M
Q4 24
$232.1M
Q3 24
$34.3M
$237.5M
Q2 24
$247.6M
Stockholders' Equity
GRDN
GRDN
VRTS
VRTS
Q1 26
$93.6B
Q4 25
$217.9M
$934.0M
Q3 25
$195.5M
$918.7M
Q2 25
$179.7M
$896.4M
Q1 25
$163.2M
$893.7M
Q4 24
$897.5M
Q3 24
$133.9M
$889.0M
Q2 24
$868.7M
Total Assets
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
$412.7M
$4.3B
Q3 25
$390.0M
$3.9B
Q2 25
$356.3M
$3.7B
Q1 25
$334.0M
$3.7B
Q4 24
$4.0B
Q3 24
$348.0M
$3.6B
Q2 24
$3.6B
Debt / Equity
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
0.00×
0.42×
Q3 25
0.43×
Q2 25
0.26×
Q1 25
0.26×
Q4 24
0.26×
Q3 24
0.26×
0.27×
Q2 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
VRTS
VRTS
Operating Cash FlowLast quarter
$34.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
$34.6M
$-67.2M
Q3 25
$28.2M
$108.3M
Q2 25
$19.9M
$75.8M
Q1 25
$17.6M
$-3.8M
Q4 24
$1.8M
Q3 24
$69.1M
Q2 24
$70.0M
Free Cash Flow
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
$-74.1M
Q3 25
$24.2M
$106.9M
Q2 25
$74.2M
Q1 25
$-6.8M
Q4 24
$-3.8M
Q3 24
$68.7M
Q2 24
$68.6M
FCF Margin
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
-35.6%
Q3 25
6.4%
49.4%
Q2 25
35.2%
Q1 25
-3.1%
Q4 24
-1.6%
Q3 24
30.3%
Q2 24
30.6%
Capex Intensity
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
3.3%
Q3 25
1.1%
0.7%
Q2 25
0.7%
Q1 25
1.4%
Q4 24
2.4%
Q3 24
0.2%
Q2 24
0.6%
Cash Conversion
GRDN
GRDN
VRTS
VRTS
Q1 26
Q4 25
1.65×
-1.99×
Q3 25
2.87×
3.45×
Q2 25
2.21×
1.77×
Q1 25
1.86×
-0.13×
Q4 24
0.04×
Q3 24
1.41×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRDN
GRDN

Segment breakdown not available.

VRTS
VRTS

Investment management fees$169.1M85%
Administration and shareholder service fees$17.3M9%
Distribution and service fees$11.6M6%

Related Comparisons